Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Clinical Medicine & Research
|
May 10, 2013
Prostate cancer risk in pre-diabetic men: a matched cohort study
Adedayo A Onitilo, Richard L Berg, Jessica M Engel, et al.
Clinical Drug Investigation
|
September 22, 2017
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Md Motiur Rahman, Yasser Alatawi, Ning Cheng, et al.
Drug Safety
|
September 21, 2018
Authors' Reply to Courtney Suggs and Colleagues' Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs"
Richard A Hansen, Ning Cheng, Md Motiur Rahman, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
April 11, 2013
Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase
Adedayo A Onitilo, Rachel V Stankowski, Richard L Berg, et al.
Drug Safety
|
December 3, 2017
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs
Ning Cheng, Md Motiur Rahman, Yasser Alatawi, et al.
Pediatrics
|
October 12, 2011
Randomized trial of a hearing conservation intervention for rural students: long-term outcomes
Barbara Marlenga, James G Linneman, William Pickett, et al.
Epilepsy Research
|
June 23, 2017
Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
Md Motiur Rahman, Yasser Alatawi, Ning Cheng, et al.
Clinical Medicine & Research
|
April 26, 2007
Evaluation of genetic factors for warfarin dose prediction
Michael D Caldwell, Richard L Berg, Kai Qi Zhang, et al.
Preventive Medicine
|
October 6, 2009
Hearing conservation program for agricultural students: short-term outcomes from a cluster-randomized trial with planned long-term follow-up
Richard L Berg, William Pickett, Marcy Fitz-Randolph, et al.
Clinical Medicine & Research
|
September 15, 2005
A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data
Michael A Hillman, Russell A Wilke, Steven H Yale, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Clinical Medicine & Research
|
May 10, 2013
Prostate cancer risk in pre-diabetic men: a matched cohort study
Adedayo A Onitilo, Richard L Berg, Jessica M Engel, et al.
Clinical Drug Investigation
|
September 22, 2017
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Md Motiur Rahman, Yasser Alatawi, Ning Cheng, et al.
Drug Safety
|
September 21, 2018
Authors' Reply to Courtney Suggs and Colleagues' Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs"
Richard A Hansen, Ning Cheng, Md Motiur Rahman, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
April 11, 2013
Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase
Adedayo A Onitilo, Rachel V Stankowski, Richard L Berg, et al.
Drug Safety
|
December 3, 2017
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs
Ning Cheng, Md Motiur Rahman, Yasser Alatawi, et al.
Pediatrics
|
October 12, 2011
Randomized trial of a hearing conservation intervention for rural students: long-term outcomes
Barbara Marlenga, James G Linneman, William Pickett, et al.
Epilepsy Research
|
June 23, 2017
Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
Md Motiur Rahman, Yasser Alatawi, Ning Cheng, et al.
Clinical Medicine & Research
|
April 26, 2007
Evaluation of genetic factors for warfarin dose prediction
Michael D Caldwell, Richard L Berg, Kai Qi Zhang, et al.
Preventive Medicine
|
October 6, 2009
Hearing conservation program for agricultural students: short-term outcomes from a cluster-randomized trial with planned long-term follow-up
Richard L Berg, William Pickett, Marcy Fitz-Randolph, et al.
Clinical Medicine & Research
|
September 15, 2005
A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data
Michael A Hillman, Russell A Wilke, Steven H Yale, et al.
Page
of 11